Cargando…
Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs
The Comprehensive in vitro Proarrhythmia Assay (CiPA) project suggested the torsade metric score (TMS) which requires substantial computing resources as a useful biomarker to predict proarrhythmic risk from human ether-à-go-go–related gene (hERG) and a few other ion channel block data. The TMS was u...
Autores principales: | Han, Sungpil, Han, Seunghoon, Kim, Ki-Suk, Lee, Hyang-Ae, Yim, Dong-Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889857/ https://www.ncbi.nlm.nih.gov/pubmed/31849669 http://dx.doi.org/10.3389/fphar.2019.01419 |
Ejemplares similares
-
Five years of the CiPA project (2013–2018): what did we learn?
por: Yim, Dong-Seok
Publicado: (2018) -
CiPA-compliant assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine
por: Amuzescu, Bogdan, et al.
Publicado: (2021) -
Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept
por: Thomet, Urs, et al.
Publicado: (2021) -
Introduction to in silico model for proarrhythmic risk assessment under the CiPA initiative
por: Park, Jin-Sol, et al.
Publicado: (2019) -
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
por: Li, Zhihua, et al.
Publicado: (2018)